APWA
Atlas Private Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,432
| Closed | -$2M | – | 185 |
|
|
2023
Q3 | $2M | Sell |
2,432
-126
| -5% | -$104K | 0.38% | 44 |
|
|
2023
Q2 | $1.84M | Buy |
2,558
+1,850
| +261% | +$1.33M | 0.37% | 49 |
|
|
2023
Q1 | $582K | Hold |
708
| – | – | 0.27% | 70 |
|
|
2022
Q4 | $511K | Sell |
708
-522
| -42% | -$377K | 0.27% | 77 |
|
|
2022
Q3 | $847K | Sell |
1,230
-3
| -0.2% | -$2.07K | 0.51% | 45 |
|
|
2022
Q2 | $729K | Buy |
1,233
+135
| +12% | +$79.8K | 0.44% | 54 |
|
|
2022
Q1 | $767K | Hold |
1,098
| – | – | 0.34% | 66 |
|
|
2021
Q4 | $693K | Buy |
1,098
+8
| +0.7% | +$5.05K | 0.32% | 74 |
|
|
2021
Q3 | $660K | Sell |
1,090
-13
| -1% | -$7.87K | 0.34% | 65 |
|
|
2021
Q2 | $616K | Buy |
1,103
+6
| +0.5% | +$3.35K | 0.33% | 72 |
|
|
2021
Q1 | $519K | Buy |
1,097
+20
| +2% | +$9.46K | 0.29% | 73 |
|
|
2020
Q4 | $520K | Buy |
1,077
+1,068
| +11,867% | +$516K | 0.35% | 66 |
|
|
2020
Q3 | $5K | Hold |
9
| – | – | ﹤0.01% | 482 |
|
|
2020
Q2 | $6K | Buy |
+9
| New | +$6K | 0.01% | 485 |
|